Does anti-aggregation with dipyridamole and aspirin help to prolong the primary patency of vascular access grafts? You have full access to this article via your institution. Patent vascular access ...

However, Todd McAllister, Nicolas L'Heureux and colleagues have now achieved encouraging results with the use of tissue-engineered vascular access grafts. In the mid-1990s, the consensus was that ...

LifeSpan ePTFE Vascular Grafts for peripheral vascular reconstructions and AV Access have been used in clinical practice for more than 15 years. It features soft ePTFE material with superb suture ...

The MAQUET line of FUSION grafts Graft merges ePTFE with PET, creating a completely new concept for peripheral vascular procedures. It delivers the easy handling of ePTFE with the reduced suture ...

Cite this: Technology Insight: The Evolution of Tissue-Engineered Vascular Grafts--From Research to Clinical Practice - Medscape - Jul 01, 2007. The recent transition to clinical use by two ...

Dialysis patients rely on vascular access—like fistulas or grafts—to filter their blood, but clots can form and block these pathways, making dialysis impossible. The research team tested ...

biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded ...

Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 ...